tibolone has been researched along with Atrophy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castelo-Branco, C; Currie, H; Mijatovic, V; Nappi, RE; Palacios, S; Rees, M; Simon, J | 1 |
| Nappi, RE; Polatti, F | 1 |
| Eyster, KM; Hansen, KA | 1 |
| Durmuşoglu, F; Eren, F; Gökaslan, H; Oktem, O | 1 |
| Berker, B; Demirel, C; Kurtay, G | 1 |
| Albertazzi, P; Killick, SR; Richmond, I; Sharma, S | 1 |
| Blum, A; Dieulangard, P; Trévoux, R | 1 |
| Antoniou, G; Botsis, D; Kalogirou, D; Karakitsos, P; Kassanos, D; Vitoratos, N | 1 |
1 review(s) available for tibolone and Atrophy
| Article | Year |
|---|---|
Update on management of genitourinary syndrome of menopause: A practical guide.
Topics: Atrophy; Complementary Therapies; Estrogen Replacement Therapy; Estrogens; Female; Humans; Laser Therapy; Menopause; Norpregnenes; Quality of Life; Selective Estrogen Receptor Modulators; Sexuality; Syndrome; Tamoxifen; Vagina; Vulva | 2015 |
3 trial(s) available for tibolone and Atrophy
| Article | Year |
|---|---|
Apoptosis in the endometrium of postmenopausal women receiving tibolone.
Topics: Apoptosis; Atrophy; Endometrium; Estrogen Receptor Modulators; Female; Humans; Immunohistochemistry; Middle Aged; Norpregnenes; Postmenopause | 2003 |
Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
Topics: Atrophy; Climacteric; Endometrium; Female; Humans; Middle Aged; Norpregnenes; Patient Dropouts; Placebos; Sweating; Uterine Hemorrhage | 1983 |
Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.
Topics: Administration, Intravaginal; Anabolic Agents; Atrophy; Climacteric; Endometrium; Endosonography; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Patient Acceptance of Health Care; Prospective Studies; Vagina | 1997 |
4 other study(ies) available for tibolone and Atrophy
| Article | Year |
|---|---|
The use of estrogen therapy in women's sexual functioning (CME).
Topics: Administration, Cutaneous; Aged; Atrophy; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norpregnenes; Sexual Dysfunction, Physiological; Vagina; Vasoconstriction | 2009 |
What happened to WHI: menopausal hormonal therapy in 2012.
Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina | 2012 |
Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen.
Topics: Administration, Cutaneous; Administration, Oral; Atrophy; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Postmenopause; Retrospective Studies; Ultrasonography; Vagina | 2004 |
Ultrasound appearance of the uterus in women over 60 years of age on tibolone: is it a SERM?
Topics: Aged; Atrophy; Endometrium; Estrogen Receptor Modulators; Female; Humans; Hysteroscopy; Middle Aged; Norpregnenes; Ultrasonography; Uterus | 2007 |